Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00120458 · ClinicalTrials.gov registry record · Phase 4
Black Cohosh as Alternative Therapy for Treating Menopause-Related Anxiety
A Phase 4 study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
NCT00120458: Completed Phase 4 study, sponsored by University of Pennsylvania.
NCT00120458 is a Phase 4 study that has completed, run by University of Pennsylvania. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00120458, a Phase 4 study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
Study Summary
This study will determine the effectiveness of the herb black cohosh for treating menopause-related anxiety symptoms in women. Study hypotheses: 1) Black cohosh will have a superior anti-anxiety effect compared to placebo. 2) Black cohosh will have a comparable safety profile to that of placebo.
Interventions
- DIETARY_SUPPLEMENT Black cohosh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2005-07 |
| Est. Completion | 2008-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00120458
The ClinicalTrials.gov registry entry for NCT00120458 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Black cohosh is the first listed.
NCT00120458 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00120458 about?
NCT00120458 is a clinical study titled "Black Cohosh as Alternative Therapy for Treating Menopause-Related Anxiety". This study will determine the effectiveness of the herb black cohosh for treating menopause-related anxiety symptoms in women. Study hypotheses: 1) Black cohosh will have a superior anti-anxiety effect compared to placebo. 2) Black cohosh will have a comparable safety profile to that of placebo.
What is the current status of trial NCT00120458?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2005-07. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00120458?
The interventions under investigation include: Black cohosh (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00120458?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.